Ghanem E Ghanem Selected Research

Ghanem E Ghanem Research Topics

Disease

24	Melanoma (Melanoma, Malignant) 01/2024 - 12/2002
17	Neoplasms (Cancer) 01/2023 - 08/2008
3	Neoplasm Metastasis (Metastasis) 10/2022 - 04/2021
2	Carcinogenesis 12/2017 - 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Fibrosarcoma 01/2020
1	Carcinoma (Carcinomatosis) 12/2017
1	Thyroid Neoplasms (Thyroid Cancer) 12/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2017
1	Skin Neoplasms (Skin Cancer) 06/2013
1	Genetic Translocation (Chromosomal Translocation) 06/2007
1	Pigmented Nevus (Melanocytic Nevus) 06/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2017
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2020 - 01/2017
3	LigandsIBA 01/2023 - 07/2018
3	Phosphotransferases (Kinase)IBA 11/2022 - 01/2020
3	Melanins (Melanin)IBA 03/2022 - 06/2013
2	Eukaryotic Initiation Factor-4EIBA 01/2024 - 01/2021
2	AntioxidantsIBA 01/2023 - 05/2021
2	ProhibitinsIBA 01/2023 - 07/2018
2	Protein Kinases (Protein Kinase)IBA 03/2022 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2017
2	Mitogen-Activated Protein KinasesIBA 04/2021 - 01/2020
2	venetoclaxIBA 01/2021 - 01/2017
2	VemurafenibIBA 08/2019 - 08/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	CrizotinibIBA 01/2023
1	olaparibIBA 01/2023
1	regorafenibIBA 11/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 11/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2022
1	Cardiac GlycosidesIBA 10/2022
1	bufalinIBA 10/2022
1	Amphibian VenomsIBA 10/2022
1	InterleukinsIBA 06/2022
1	CytokinesIBA 06/2022
1	ChemokinesIBA 06/2022
1	Glutathione (Reduced Glutathione)IBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Radioisotopes (Radionuclides)IBA 05/2021
1	Peptide Receptors (Peptide Receptor)IBA 05/2021
1	Growth Factor ReceptorsIBA 04/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Proto-Oncogene Proteins c-metIBA 04/2021
1	tyrosine receptor (receptor, tyrosine)IBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	AntigensIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2020
1	nilotinib FDA Link 04/2020
1	Free RadicalsIBA 08/2019
1	Sulfhydryl Compounds (Thiols)IBA 08/2019
1	GalactosidasesIBA 08/2018
1	melanogeninIBA 07/2018
1	Galectins (Galectin)IBA 12/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 11/2017
1	Microphthalmia-Associated Transcription FactorIBA 01/2017
1	Drug CombinationsIBA 01/2017
1	Cytostatic AgentsIBA 01/2017
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2016
1	Alkylating AgentsIBA 08/2008
1	Peptide Hydrolases (Proteases)FDA Link 08/2008
1	ProdrugsIBA 08/2008
1	Peptides (Polypeptides)IBA 08/2008
1	p-FluorophenylalanineIBA 08/2008
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 08/2008
1	Guanosine Triphosphate (GTP)IBA 06/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2002
1	NF-kappa B (NF-kB)IBA 12/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2002
1	Transcription Factors (Transcription Factor)IBA 12/2002
1	alpha-MSHIBA 12/2002

Therapy/Procedure

9	Therapeutics 01/2023 - 07/2012
4	Radiotherapy 12/2023 - 08/2019
2	Immunotherapy 01/2021 - 01/2021
1	Drug Therapy (Chemotherapy) 01/2009